$1.62 Billion is the total value of BVF INC/IL's 57 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 28.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SWTX | Sell | SPRINGWORKS THERAPEUTICS INC | $96,049,000 | +28.5% | 2,286,891 | -17.4% | 5.92% | -15.0% |
| PRNB | Sell | PRINCIPIA BIOPHARMA INC | $88,769,000 | -5.6% | 1,484,674 | -6.2% | 5.47% | -37.6% |
| ARGX | Buy | ARGENX SEsponsored adr | $87,840,000 | +2567.5% | 390,000 | +1460.0% | 5.42% | +1664.2% |
| IONS | Sell | IONIS PHARMACEUTICALS INC | $83,891,000 | -8.8% | 1,422,842 | -26.8% | 5.17% | -39.6% |
| MRUS | Buy | MERUS N V | $81,907,000 | +91.0% | 5,090,571 | +43.6% | 5.05% | +26.3% |
| XOMA | Buy | XOMA CORP DEL | $79,557,000 | +41.0% | 4,026,157 | +45.2% | 4.90% | -6.7% |
| ACIU | Sell | AC IMMUNE SA | $76,175,000 | -2.8% | 11,318,758 | -0.2% | 4.70% | -35.7% |
| XNCR | Buy | XENCOR INC | $66,986,000 | +32.7% | 2,068,098 | +22.4% | 4.13% | -12.2% |
| RPTX | New | REPARE THERAPEUTICS INC | $60,320,000 | – | 1,944,546 | +100.0% | 3.72% | – |
| REPL | Buy | REPLIMUNE GROUP INC | $57,529,000 | +192.1% | 2,315,053 | +17.2% | 3.55% | +93.3% |
| FPRX | Buy | FIVE PRIME THERAPEUTICS INC | $48,727,000 | +175.8% | 7,988,053 | +2.6% | 3.00% | +82.4% |
| RCUS | Buy | ARCUS BIOSCIENCES INC | $46,579,000 | +8606.4% | 1,882,722 | +4780.8% | 2.87% | +5644.0% |
| IDYA | Buy | IDEAYA BIOSCIENCES INC | $45,852,000 | +766.3% | 3,226,769 | +151.1% | 2.83% | +473.4% |
| KURA | Buy | KURA ONCOLOGY INC | $45,247,000 | +86.8% | 2,775,882 | +14.0% | 2.79% | +23.6% |
| XENE | Buy | XENON PHARMACEUTICALS INC | $44,101,000 | +45.4% | 3,516,851 | +31.5% | 2.72% | -3.8% |
| PTGX | Buy | PROTAGONIST THERAPEUTICS INC | $41,806,000 | +755.1% | 2,367,288 | +241.9% | 2.58% | +465.4% |
| CALA | Sell | CALITHERA BIOSCIENCES INC | $37,439,000 | -11.8% | 7,090,638 | -25.8% | 2.31% | -41.7% |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $36,615,000 | +56.0% | 2,470,678 | +15.5% | 2.26% | +3.2% |
| CLDX | New | CELLDEX THERAPEUTICS INC NEW | $35,620,000 | – | 2,740,000 | +100.0% | 2.20% | – |
| MTEM | Sell | MOLECULAR TEMPLATES INC | $29,635,000 | -21.8% | 2,149,057 | -24.6% | 1.83% | -48.3% |
| ANAB | Sell | ANAPTYSBIO INC | $28,917,000 | +21.1% | 1,294,401 | -23.4% | 1.78% | -19.9% |
| GLYC | Sell | GLYCOMIMETICS INC | $27,238,000 | +62.3% | 7,244,262 | -1.6% | 1.68% | +7.4% |
| IMVT | Buy | IMMUNOVANT INC | $26,504,000 | +70.3% | 1,088,479 | +8.8% | 1.63% | +12.6% |
| CTMX | Sell | CYTOMX THERAPEUTICS INC | $25,952,000 | -13.7% | 3,115,537 | -20.6% | 1.60% | -42.9% |
| RVMD | Sell | REVOLUTION MEDICINES INC | $25,202,000 | -17.7% | 798,286 | -42.9% | 1.55% | -45.6% |
| SELB | Buy | SELECTA BIOSCIENCES INC | $23,557,000 | +170.8% | 8,294,547 | +129.8% | 1.45% | +79.0% |
| STRO | Buy | SUTRO BIOPHARMA INC | $18,379,000 | +278.9% | 2,368,392 | +398.1% | 1.13% | +150.7% |
| OVID | Buy | OVID THERAPEUTICS INC | $17,630,000 | +360.1% | 2,392,151 | +86.0% | 1.09% | +204.5% |
| CALT | New | CALLIDITAS THERAPEUTICS ABsponsored ads | $17,475,000 | – | 750,000 | +100.0% | 1.08% | – |
| MEIP | Sell | MEI PHARMA INC | $17,058,000 | +110.0% | 4,130,162 | -18.2% | 1.05% | +39.0% |
| BDTX | BLACK DIAMOND THERAPEUTICS INC | $15,970,000 | +69.0% | 378,788 | 0.0% | 0.98% | +11.8% | |
| INFI | INFINITY PHARMACEUTICALS INC | $15,764,000 | +8.0% | 17,426,968 | 0.0% | 0.97% | -28.6% | |
| FBRX | New | FORTE BIOSCIENCES INC | $14,272,000 | – | 978,857 | +100.0% | 0.88% | – |
| CDTX | Sell | CIDARA THERAPEUTICS INC | $13,613,000 | +43.5% | 3,689,203 | -3.6% | 0.84% | -5.1% |
| SURF | Buy | SURFACE ONCOLOGY INC | $13,373,000 | +627.6% | 2,038,528 | +107.4% | 0.82% | +382.5% |
| EPIX | Sell | ESSA PHARMA INC | $12,306,000 | +27.1% | 1,984,889 | -18.0% | 0.76% | -15.9% |
| PHAT | Sell | PHATHOM PHARMACEUTICALS INC | $10,600,000 | -39.3% | 322,098 | -52.4% | 0.65% | -59.8% |
| CFRX | New | CONTRAFECT CORP | $10,224,000 | – | 1,600,000 | +100.0% | 0.63% | – |
| GMDA | Buy | GAMIDA CELL LTD | $9,797,000 | +224.4% | 2,143,667 | +114.4% | 0.60% | +114.9% |
| PIRS | Sell | PIERIS PHARMACEUTICALS INC | $9,658,000 | -27.9% | 3,115,382 | -47.0% | 0.60% | -52.3% |
| XFOR | Sell | X4 PHARMACEUTICALS INC | $9,422,000 | -19.6% | 1,010,892 | -13.7% | 0.58% | -46.8% |
| VSTM | Sell | VERASTEM INC | $8,650,000 | -48.2% | 5,028,994 | -20.5% | 0.53% | -65.8% |
| GLMD | Sell | GALMED PHARMACEUTICALS LTD | $8,603,000 | +35.7% | 1,799,694 | -1.8% | 0.53% | -10.3% |
| CTIC | CTI BIOPHARMA CORP | $8,038,000 | +26.1% | 6,929,690 | 0.0% | 0.50% | -16.5% | |
| SPRO | Sell | SPERO THERAPEUTICS INC | $6,583,000 | +44.6% | 486,540 | -13.6% | 0.41% | -4.2% |
| EVLO | New | EVELO BIOSCIENCES INC | $6,370,000 | – | 1,300,000 | +100.0% | 0.39% | – |
| ERYP | ERYTECH PHARMAsponsored adr | $5,263,000 | +57.7% | 625,000 | 0.0% | 0.32% | +4.2% | |
| CRVS | Sell | CORVUS PHARMACEUTICALS INC | $4,739,000 | +4.1% | 1,742,112 | -19.2% | 0.29% | -31.1% |
| GNCA | Sell | GENOCEA BIOSCIENCES INC | $4,642,000 | +28.5% | 2,018,398 | -3.9% | 0.29% | -15.1% |
| CRIS | New | CURIS INC | $4,417,000 | – | 3,650,000 | +100.0% | 0.27% | – |
| FWP | Sell | FORWARD PHARMA A/Ssponsord ads new | $3,968,000 | -26.2% | 647,299 | -30.1% | 0.24% | -51.1% |
| BLRX | Sell | BIOLINERX LTDsponsored ads | $2,884,000 | +25.1% | 1,686,375 | -2.7% | 0.18% | -17.2% |
| SBPH | Sell | SPRING BK PHARMACEUTICALS INC | $1,384,000 | +56.4% | 941,171 | -1.1% | 0.08% | +3.7% |
| RGLS | Sell | REGULUS THERAPEUTICS INC | $988,000 | +34.6% | 1,450,000 | -9.0% | 0.06% | -10.3% |
| NVUS | Buy | NOVUS THERAPEUTICS INC | $818,000 | +206.4% | 1,785,000 | +160.7% | 0.05% | +100.0% |
| SNSS | Sell | SUNESIS PHARMACEUTICALS INC | $684,000 | -73.4% | 2,594,925 | -58.1% | 0.04% | -82.5% |
| EXEL | New | EXELIXIS INC | $363,000 | – | 15,300 | +100.0% | 0.02% | – |
| EIGR | Exit | EIGER BIOPHARMACEUTICALS INC | $0 | – | -68,054 | -100.0% | -0.04% | – |
| GLPG | Exit | GALAPAGOS NVspon adr | $0 | – | -7,674 | -100.0% | -0.14% | – |
| ALPN | Exit | ALPINE IMMUNE SCIENCES INC | $0 | – | -1,137,764 | -100.0% | -0.30% | – |
| PRVL | Exit | PREVAIL THERAPEUTICS INC | $0 | – | -431,483 | -100.0% | -0.49% | – |
| AKRO | Exit | AKERO THERAPEUTICS INC | $0 | – | -282,862 | -100.0% | -0.56% | – |
| KZR | Exit | KEZAR LIFE SCIENCES INC | $0 | – | -1,564,373 | -100.0% | -0.64% | – |
| MRSN | Exit | MERSANA THERAPEUTICS INC | $0 | – | -2,372,400 | -100.0% | -1.29% | – |
| CYTK | Exit | CYTOKINETICS INC | $0 | – | -3,938,280 | -100.0% | -4.33% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| XENON PHARMACEUTICALS INC | 36 | Q3 2023 | 4.7% |
| PIERIS PHARMACEUTICALS INC | 30 | Q3 2023 | 2.8% |
| CYTOKINETICS INC | 29 | Q4 2020 | 11.8% |
| INFINITY PHARMACEUTICALS INC | 29 | Q2 2023 | 4.3% |
| XOMA CORP DEL | 28 | Q3 2023 | 7.3% |
| ARQULE INC | 27 | Q4 2019 | 4.8% |
| CHEMOCENTRYX INC | 26 | Q3 2019 | 13.8% |
| CYTOMX THERAPEUTICS INC | 26 | Q3 2023 | 5.3% |
| CORVUS PHARMACEUTICALS INC | 26 | Q3 2023 | 2.3% |
| ARRAY BIOPHARMA INC | 25 | Q2 2019 | 14.5% |
View BVF INC/IL's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 4 | 2024-01-29 |
| 3 | 2024-01-26 |
| 4 | 2024-01-09 |
| 4 | 2023-12-20 |
| 4 | 2023-11-17 |
| 13F-HR | 2023-11-14 |
| 3 | 2023-11-13 |
| 3 | 2023-11-06 |
| 4 | 2023-11-06 |
View BVF INC/IL's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.